NCT03951987 - Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of Charcoal | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions

Pharmacokinetic

Interventions

DRUG

4 ml CG5503

4 ml of the CG5503 infusion solution corresponding to 40 mg CG5503 (tapentadol hydrochloride).

DRUG

5 g charcoal powder

Oral administration of 5 g charcoal powder suspended in 100 ml tap water.

Trial Locations (1)

Department of Clinical Pharmacology Grünenthal GmbH, Aachen